Apellis Pharmaceuticals (APLS) PT Raised to $96 at Baird
Tweet Send to a Friend
(Updated - August 9, 2024 6:38 AM EDT)
Baird analyst Colleen Kusy raised the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Colleen Kusy raised the price target on Apellis Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
